CN1371735A - Phospholipid capsule compsotiion with effective blood-lipid regulation function - Google Patents
Phospholipid capsule compsotiion with effective blood-lipid regulation function Download PDFInfo
- Publication number
- CN1371735A CN1371735A CN 02111084 CN02111084A CN1371735A CN 1371735 A CN1371735 A CN 1371735A CN 02111084 CN02111084 CN 02111084 CN 02111084 A CN02111084 A CN 02111084A CN 1371735 A CN1371735 A CN 1371735A
- Authority
- CN
- China
- Prior art keywords
- phospholipid
- lipid regulation
- ethyl linoleate
- capsule
- compsotiion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The composition of phospholipid capsule as health-care contains (by weight portion) 40-50 portions of soya lecithin, 10-15 portions of ethyl linoleate, 37-48 portions of refined soybean oil and 2-3 portions of span 80. It is mainly used for regulating blood-lipid and raising immanity of human body.
Description
One, technical field
The present invention relates to a kind of phospholipid health food, particularly a kind of phospholipid capsule content with obvious blood lipid regulation effect, this capsule have tangible blood lipid regulation, improve the health-care effect of immunity.
Two, background technology
Phospholipid is one of basic substance of life, it is the indispensable necessary composition of function of human body, report according to special commission of World Health Organization (WHO), common people need replenish 6-8 gram phospholipid every day, the phospholipid of edible 22-85 gram can reduce the cholesterol in the blood, and (king that China Light Industry Press publishes is put, Wang Xianlun chief editor's food nutrition keeps healthy principle and technology) without any side effects.Therefore, phospholipid is the 21st century pure natural health-care.It is primary raw material that present commercially available phospholipid capsule all adopts single phospholipid, and Chinese patent ZI99113150.9 discloses " phospholipid capsule preparation ", and its phospholipid accounts for more than 90% in component.Adopt capsule can solve the edible trouble of phospholipid, the relatively poor drawback of mouthfeel, though to improving body immunity tangible effect is arranged, because taking dose is little at ordinary times, the effect of blood lipid regulation seems very little.Nearly 10 for many years, scientist has biological effect and physiologically active widely by discovering Ethyl linoleate in human body, therefore the effect (state sends daughter-in-law children health care fascicle, 1996 the 7th the 3rd phases of volume outside) that has obvious cholesterol reducing, blood fat reducing and triglyceride.But do not find its synergitic use.
Three, summary of the invention
The technical issues that need to address of the present invention are: a kind of prescription of phospholipid capsule content is provided, and this prescription has been strengthened the synergism of phospholipid and Ethyl linoleate.Its technical scheme is: a kind of phospholipid capsule content with obvious blood lipid regulation effect, comprise soybean phospholipid, Oleum Glycines, emulsifying agent department basis 80, it is characterized in that this content also comprises Ethyl linoleate, the weight proportion of each component is as follows: soybean phospholipid 40-50 part, Ethyl linoleate 10-15 part, refining Oleum Glycines 37-48, these 80 2-3 parts of department.The effect that the present invention is mainly used in blood lipid regulation and improves body immunity.The invention has the beneficial effects as follows: because the synergism of phospholipid and Ethyl linoleate when improving body immunity, has the effect of obvious blood lipid regulation.In 100 gram contents, Ethyl linoleate (in oil) 〉=50%, lecithin is (with C
46H
86Q
9The PN meter) 〉=30%, check through Shanghai City health and epidemic prevention station, can reduce serum cholesterol and the triglyceride content of hyperlipemia rat, rising blood concentration lipoprotein, improve the cytoactive of rat, engulfing and phagocytic index and cellular immune level of macrophage has blood lipid regulation and immunoregulation effect.
Four, the specific embodiment
Embodiment 1: a kind of phospholipid capsule content with obvious blood lipid regulation effect, comprise soybean phospholipid, Ethyl linoleate, Oleum Glycines, emulsifying agent department basis 80, in 100 grams, concrete proportioning is: soybean phospholipid 43 grams, Ethyl linoleate 12 grams, refining Oleum Glycines 42 grams, this 80 3 gram of department at first adds refining Oleum Glycines by prescription, add soybean phospholipid, Ethyl linoleate and department's basis 80 more successively, heat 55-65 ℃ of stirring,, on conventional production line, produce capsule then until even.
Embodiment 2: soybean phospholipid, Ethyl linoleate, Oleum Glycines, emulsifying agent department this 80, in 100 grams, concrete proportioning is: soybean phospholipid 47 grams, Ethyl linoleate 13 grams, refining Oleum Glycines 38 grams, this 80 2 gram of department, all the other are identical with embodiment 1.
Claims (2)
1, a kind of phospholipid capsule content with obvious blood lipid regulation effect, comprise soybean phospholipid, Oleum Glycines, emulsifying agent department basis 80, it is characterized in that this content also comprises Ethyl linoleate, the weight proportion of each component is as follows: soybean phospholipid 40-50 part, Ethyl linoleate 10-15 part, refining Oleum Glycines 37-48, these 80 2-3 parts of department.
2, a kind of purposes of the content of phospholipid capsule according to claim 1 is characterized in that: the health food that is mainly used in blood lipid regulation and raising body immunity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021110840A CN1152709C (en) | 2002-03-19 | 2002-03-19 | Phospholipid capsule compsotiion with effective blood-lipid regulation function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021110840A CN1152709C (en) | 2002-03-19 | 2002-03-19 | Phospholipid capsule compsotiion with effective blood-lipid regulation function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1371735A true CN1371735A (en) | 2002-10-02 |
| CN1152709C CN1152709C (en) | 2004-06-09 |
Family
ID=4741388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021110840A Expired - Fee Related CN1152709C (en) | 2002-03-19 | 2002-03-19 | Phospholipid capsule compsotiion with effective blood-lipid regulation function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1152709C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103844270A (en) * | 2012-12-04 | 2014-06-11 | 洛阳花瓣舞生物技术有限公司 | Hypolipidemic compound peony seed oil soft capsule |
| CN104306383A (en) * | 2014-09-22 | 2015-01-28 | 广州市赛健生物科技有限公司 | Phosphatide soft capsule and preparation method thereof |
-
2002
- 2002-03-19 CN CNB021110840A patent/CN1152709C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103844270A (en) * | 2012-12-04 | 2014-06-11 | 洛阳花瓣舞生物技术有限公司 | Hypolipidemic compound peony seed oil soft capsule |
| CN104306383A (en) * | 2014-09-22 | 2015-01-28 | 广州市赛健生物科技有限公司 | Phosphatide soft capsule and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1152709C (en) | 2004-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919383A (en) | Blend oil containing peony seed oil and preparation method of blend oil | |
| CN101965971B (en) | Walnut hemp oil health food | |
| CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
| CN103300447A (en) | Wellness enzyme beverage capable of promoting in-vivo metabolism and coordinating intestine and stomach functions and preparation method thereof | |
| CN1152709C (en) | Phospholipid capsule compsotiion with effective blood-lipid regulation function | |
| TWI612905B (en) | A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement | |
| CN102106411A (en) | Nutrient oil for diabetics | |
| CN101715984B (en) | Spirulina capsule and manufacturing process thereof | |
| CN1060046C (en) | Nutritive health products of wood frog oil | |
| CN101129698B (en) | Eye drops containing turmeric extractive and preparation method thereof | |
| CN1095676C (en) | Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity | |
| CN1278616C (en) | Healthy edible oil with coenzyme Q10 | |
| CN1251703C (en) | Soft capsule made of walnut oil for taking care of brain health | |
| US6979457B2 (en) | Food supplement formulation | |
| CN103271172A (en) | Health-care blending corn oil and preparation method thereof | |
| CN102755444A (en) | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof | |
| CN101273776A (en) | Weikang soft capsules and producing process thereof | |
| CN100536866C (en) | Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin | |
| CN101507488A (en) | Composite reinforced nutritious chicken essence | |
| CN101411491A (en) | Health-care flour | |
| CN1097602A (en) | The prescription of Ant Queen Wine and preparation method | |
| CN102232431A (en) | Health-care oil | |
| CN116261977A (en) | Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg | |
| CN1230369A (en) | Slimming health food of natural plant | |
| CN104432067A (en) | Health food for relieving female climacteric syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANGHAI JINBAN FOODS CO., LTD.; SHANGHAI JINBAN Free format text: FORMER OWNER: SHANGHAI JINBAN FOODS CO., LTD. Effective date: 20060915 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20060915 Address after: 201204 Shanghai Pudong New Area Beicai Chenchun Road No. 200 Co-patentee after: Shanghai Jinban Pharmaceutical Co., Ltd. Patentee after: Shanghai Jinban Foods Co., Ltd. Address before: 201204 Shanghai Pudong New Area Beicai Chenchun Road No. 200 Patentee before: Shanghai Jinban Foods Co., Ltd. |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040609 Termination date: 20100319 |